BioCentury | May 13, 2019
Financial News

MGI Tech raises $200M for high throughput gene sequencers

Sequencing technology company MGI Tech raised over $200 million in an undisclosed financing backed by CITIC Goldstone Capital, Green Pine Capital Partners and Orient Securities Capital Investment. MGI Tech Co. Ltd. said it plans to...
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

A near decade-long run of cheap money appears to be coming to a close, and most of the biotech sector isn’t well positioned for the new reality. BioCentury’s analysis shows that two-thirds of biotech companies...
BioCentury | Jan 19, 2018
Financial News

China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Kunshan, China) each completed financings, raising more than $100 million combined. Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series...
BioCentury | Jan 16, 2018
Financial News

China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) each completed financings, raising more than $100 million combined. Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series...
BioCentury | Jan 13, 2018
Finance

Choosy investors

Despite losing steam in 4Q17, the broad-based recovery in biotech stocks last year has left investors generally comfortable with current valuations, and hence less optimistic that the sector indexes will outpace the broader market in...
BioCentury | Jul 18, 2011
Financial News

RaQualia completes IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Date completed: 7/8/11 Type: IPO Raised: ¥6.4 billion ($79.4 million) Shares: 4 million Price: ¥1,600 Shares after offering: 13.3 million Underwriters: Daiwa Securities Capital Markets; and...
BioCentury | Jun 20, 2011
Financial News

RaQualia amends IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Date announced: 6/16/11 Type: IPO To be raised: TBD Shares: 4 million Price: TBD Underwriters: Daiwa Securities Capital Markets; and other underwriters Overallotment: TBD Note: RaQualia...
BioCentury | Mar 21, 2011
Financial News

RaQualia postpones IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Type: IPO Underwriters: Daiwa Securities Capital Markets Note: RaQualia postponed its IPO on the JASDAQ Growth Market of the Osaka Securities Exchange, citing extraordinary circumstances due...
BioCentury | Feb 28, 2011
Financial News

RaQualia proposes IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Date announced: 2/21/11 Type: IPO To be raised: TBD Shares: 3.7 million Price: TBD Underwriter: Daiwa Securities Capital Markets Note: The offering is also being underwritten...
BioCentury | Feb 19, 2002
Politics, Policy & Law

Germany switches patent power

Germany has taken a step that should make it easier to commercialize inventions made in academia. Starting this month, German universities and academic research institutions are allowed to file for patents on inventions made by...
Items per page:
1 - 10 of 12
BioCentury | May 13, 2019
Financial News

MGI Tech raises $200M for high throughput gene sequencers

Sequencing technology company MGI Tech raised over $200 million in an undisclosed financing backed by CITIC Goldstone Capital, Green Pine Capital Partners and Orient Securities Capital Investment. MGI Tech Co. Ltd. said it plans to...
BioCentury | Jan 12, 2019
Finance

Warning: cash needed

A near decade-long run of cheap money appears to be coming to a close, and most of the biotech sector isn’t well positioned for the new reality. BioCentury’s analysis shows that two-thirds of biotech companies...
BioCentury | Jan 19, 2018
Financial News

China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Kunshan, China) each completed financings, raising more than $100 million combined. Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series...
BioCentury | Jan 16, 2018
Financial News

China's Kintor, Zelgen complete financings

Suzhou Kintor Pharmaceuticals Inc. (Suzhou, China) and Suzhou Zelgen Biopharmaceuticals Co. Ltd. (Suzhou, China) each completed financings, raising more than $100 million combined. Kintor raised RMB288 million ($44.7 million) on Jan. 11 in a series...
BioCentury | Jan 13, 2018
Finance

Choosy investors

Despite losing steam in 4Q17, the broad-based recovery in biotech stocks last year has left investors generally comfortable with current valuations, and hence less optimistic that the sector indexes will outpace the broader market in...
BioCentury | Jul 18, 2011
Financial News

RaQualia completes IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Date completed: 7/8/11 Type: IPO Raised: ¥6.4 billion ($79.4 million) Shares: 4 million Price: ¥1,600 Shares after offering: 13.3 million Underwriters: Daiwa Securities Capital Markets; and...
BioCentury | Jun 20, 2011
Financial News

RaQualia amends IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Date announced: 6/16/11 Type: IPO To be raised: TBD Shares: 4 million Price: TBD Underwriters: Daiwa Securities Capital Markets; and other underwriters Overallotment: TBD Note: RaQualia...
BioCentury | Mar 21, 2011
Financial News

RaQualia postpones IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Type: IPO Underwriters: Daiwa Securities Capital Markets Note: RaQualia postponed its IPO on the JASDAQ Growth Market of the Osaka Securities Exchange, citing extraordinary circumstances due...
BioCentury | Feb 28, 2011
Financial News

RaQualia proposes IPO

RaQualia Pharma Inc. , Aichi, Japan Business: Infectious, Neurology, Gastrointestinal Date announced: 2/21/11 Type: IPO To be raised: TBD Shares: 3.7 million Price: TBD Underwriter: Daiwa Securities Capital Markets Note: The offering is also being underwritten...
BioCentury | Feb 19, 2002
Politics, Policy & Law

Germany switches patent power

Germany has taken a step that should make it easier to commercialize inventions made in academia. Starting this month, German universities and academic research institutions are allowed to file for patents on inventions made by...
Items per page:
1 - 10 of 12